How does Novartis AG make money?

Novartis makes money by discovering, developing, manufacturing, and commercializing patented medicines across cardiovascular, renal and metabolic, immunology, neuroscience, and oncology markets.

What is Novartis AG's business model?

Novartis AG is a public company headquartered in Basel, Switzerland that operates in Innovative medicines and pharmaceuticals. Novartis makes money by discovering, developing, manufacturing, and commercializing patented medicines across cardiovascular, renal and metabolic, immunology, neuroscience, and oncology markets.

What is Novartis AG's growth strategy?

Novartis AG's growth strategy centers on this advantage: Novartis's advantage is a focused patented-medicine portfolio, global commercial reach, scale in clinical development, and specialty platforms such as radioligand therapy.

What is Novartis AG's revenue?

Novartis AG reported approximately $54.53B in annual revenue.

What industry does Novartis AG operate in?

Novartis AG operates in the Innovative medicines and pharmaceuticals industry. The company is headquartered in Basel, Switzerland.

Is Novartis AG profitable?

Yes, Novartis AG is profitable. The company generates approximately $54.53B in annual revenue and reports positive net income.

How Does Novartis Make Money?

CorpDigest

Search companiesSearchK Contact

Novartis AG

PharmaceuticalsFounded 1996

Reviewed by Swet Parvadiya

Last reviewed: July 2026

Explore Novartis

Core profile pages, annual revenue records, and related research hubs for this company.

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.

How Novartis Makes Money

Revenue Model & Pricing

Growth Strategy

Related Companies

Compare Novartis AG With Competitors

How Novartis Makes Money

Revenue Model & Pricing

Growth Strategy

Related Companies

Compare Novartis AG With Competitors